Following completion of its satisfactory due diligence investigations, Mitr Phol has today announced that it intends to make an all cash offer for MSF at $4.45 per share, which values MSF at approximately $313 million. The Board of MSF has indicated that it intends to recommend the offer to MSF shareholders, in the absence of a superior proposal and subject to an independent expert determining that the offer is fair and reasonable.
The Mallesons team is being led by Brisbane partner John Humphrey together with senior associate Rhys Casey. Greenhill Caliburn is also advising MSF.
Commenting on the deal, Humphrey said "It was a great effort by the MSF, Mallesons and Greenhill Caliburn team following receipt of Mitr Phol's proposal to negotiate and agree the terms of the takeover in such a short timeframe so that, following completion of a short due diligence process, the offer can be presented to shareholders."
Elle QuinnCommunications ManagerT +61 2 9296 3730
M +61 424 168 080